Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (138)
- User Facilities (28)
Researcher
- Brian Post
- Chris Tyler
- Justin West
- Peter Wang
- Andrzej Nycz
- Ritin Mathews
- Blane Fillingim
- Chris Masuo
- Peeyush Nandwana
- Sudarsanam Babu
- Thomas Feldhausen
- Adam Stevens
- Ahmed Hassen
- David Olvera Trejo
- J.R. R Matheson
- Jaydeep Karandikar
- Joshua Vaughan
- Lauren Heinrich
- Michael Kirka
- Rangasayee Kannan
- Ryan Dehoff
- Scott Smith
- William Carter
- Yousub Lee
- Akash Jag Prasad
- Alex Roschli
- Amir K Ziabari
- Amit Shyam
- Amy Elliott
- Beth L Armstrong
- Brian Gibson
- Bruce Moyer
- Calen Kimmell
- Cameron Adkins
- Christopher Fancher
- Christopher Ledford
- Corson Cramer
- Craig Blue
- Debjani Pal
- Emma Betters
- Fred List III
- Gordon Robertson
- Greg Corson
- Isha Bhandari
- James Klett
- Jay Reynolds
- Jeff Brookins
- Jeffrey Einkauf
- Jennifer M Pyles
- Jesse Heineman
- John Lindahl
- John Potter
- Josh B Harbin
- Justin Griswold
- Keith Carver
- Kuntal De
- Laetitia H Delmau
- Liam White
- Luke Meyer
- Luke Sadergaski
- Michael Borish
- Mike Zach
- Padhraic L Mulligan
- Philip Bingham
- Richard Howard
- Roger G Miller
- Sandra Davern
- Sarah Graham
- Steve Bullock
- Steven Guzorek
- Thomas Butcher
- Tony L Schmitz
- Trevor Aguirre
- Venkatakrishnan Singanallur Vaidyanathan
- Vincent Paquit
- Vladimir Orlyanchik
- Vlastimil Kunc
- William Peter
- Yukinori Yamamoto

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

Simurgh revolutionizes industrial CT imaging with AI, enhancing speed and accuracy in nondestructive testing for complex parts, reducing costs.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence

An innovative rapid manufacturing method for tailored fiber preforms with controlled fiber alignment for enhanced mechanical properties.